Status:

UNKNOWN

Leaving Nobody Out

Lead Sponsor:

Guy's and St Thomas' NHS Foundation Trust

Conditions:

HIV Infections

Eligibility:

All Genders

18-110 years

Brief Summary

Established recruitment methods will be used to recruit participants. The study will be non-blinded. Eligibility will be checked and consent taken by a delegated study clinician. Participants will att...

Detailed Description

Study description and population to be studied: Researchers will employ Implementation Science methodology to understand and act upon the determinants of representation in HIV clinical studies in ord...

Eligibility Criteria

Inclusion

  • Inclusion criteria for initial analysis to identify groups who are underrepresented:
  • HIV positive
  • ≥18 years old
  • Registered to receive care under Harrison Wing (and thus potential candidates for Harrison Wing clinical studies) at any point in the period between 01/01/2017 and 31/12/2019 inclusive. The period 01/01/2017 and 31/12/2019 has been selected because it is recent, occurred prior to the disruption caused by the Covid-19 pandemic and there exists complete data regarding HIV clinical study participation during this time.
  • Inclusion criteria for Groups 1 and 2 of the virtual semi-structured interview aspect of this study:
  • Group 1:
  • HIV positive
  • ≥18 years old
  • Currently registered to receive care under Harrison Wing (and thus potential candidates for Harrison Wing clinical studies)
  • Has ≥ 1 demographic identified to be underrepresented as specified in 'trial statistics'
  • Able and willing to provide written or witnessed informed consent to participate
  • Group 2:
  • HIV positive
  • ≥18 years old
  • Currently registered to receive care under Harrison Wing
  • Currently participating in any clinical study in which Harrison Wing is the/ a participating centre
  • Able and willing to provide written or witnessed informed consent to participate
  • Inclusion criteria for self-administered surveys:
  • HIV positive
  • ≥18 years old
  • Registered to receive care under Harrison Wing (and thus potential candidates for Harrison Wing clinical studies)

Exclusion

  • \-

Key Trial Info

Start Date :

May 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 30 2023

Estimated Enrollment :

3520 Patients enrolled

Trial Details

Trial ID

NCT05306769

Start Date

May 1 2022

End Date

April 30 2023

Last Update

April 1 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.